We are live on
!
Find out more
SCM
Sage Capital Management Portfolio holdings
AUM
$256M
1-Year Est. Return
29.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.43%
1 Year Est. Return
+29.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
-$10.5M
(-5%)
Cap. Flow
-$9.68M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
35.33%
Holding
165
New
2
Increased
62
Reduced
65
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unum
UNM
|
+$201K |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$106K |
| 3 |
NVIDIA
NVDA
|
+$98.8K |
| 4 |
BXMX
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$67.1K |
| 5 |
CrowdStrike
CRWD
|
+$49.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HQH
abrdn Healthcare Investors
HQH
|
+$921K |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727K |
| 3 |
IBM
IBM
|
+$586K |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$417K |
| 5 |
ExxonMobil
XOM
|
+$375K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.43% |
| 2 | Real Estate | 5.65% |
| 3 | Consumer Discretionary | 1.97% |
| 4 | Healthcare | 1.89% |
| 5 | Energy | 1.86% |
Similar funds
CIA
PHAM
HFRG
KAM
EBWM
HP
GCCM
Sage Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Sage Capital Management held 165 positions worth $198M, down 5% from $208M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Sage Capital Management withdrew a net $9.68M in Q4 2024, closing 8 positions and reducing 65 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $220K position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Real Estate and Consumer Discretionary.
Against the trend, Sage Capital Management opened a new position in Unum worth $213K.
- Sage Capital Management's largest Q4 2024 buy was Unum: 2,921 shares worth $213K.
- Sage Capital Management added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2024, an estimated $106K increase.
- Sage Capital Management's biggest Q4 2024 reduction was abrdn Healthcare Investors, cutting an estimated $921K.
- Sage Capital Management fully exited Vertex Pharmaceuticals in Q4 2024, selling an estimated $220K.
- Sage Capital Management's ten largest holdings make up 35% of its $198M portfolio in Q4 2024.
- Sage Capital Management opened 2 new positions and closed 8 in Q4 2024.
- Sage Capital Management's portfolio value fell 5% quarter-over-quarter to $198M.
Based on Sage Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.